Virology & Mycology
Open Access
ISSN: 2161-0517
ISSN: 2161-0517
Gurfateh Singh
Rayat Bahra University, India
Scientific Tracks Abstracts: Virol Mycol
Objective: The present study has been designed to investigate the beneficial role of Fenofibrate & Clofibrate in attenuated the cardioprotective effect of ischemic preconditioning (IPC) in hyperlipidemic rat heart. Materials & Methods: Experimental hyperlipidemia was produced by feeding high fat diet to rats for a period of 28 days. Isolated langendorffâ��s perfused normal and hyperlipidemic rat hearts were subjected to global ischemia for 30 min followed by reperfusion for 120 min. The myocardial infarct size was assessed macroscopically using triphenyltetrazolium chloride staining. Coronary effluent was analyzed for lactate dehydrogenase (LDH) and creatine kinase-MB release to assess the extent of cardiac injury. Moreover, the oxidative stress in heart was assessed by measuring thiobarbituric acid reactive substance, superoxide anion generation and reduced form of glutathione. Results: The ischemia-reperfusion (I/R) has been noted to induce oxidative stress by increasing TBARS, superoxide anion generation and decreasing reduced form of glutathione in normal and hyperlipidemic rat hearts. Moreover, I/R produced myocardial injury, which was assessed in terms of increase in myocardial infarct size, LDH and CK-MB release in coronary effluent and decrease in coronary flow rate in normal and hyperlipidemic rat heart. In addition, the hyperlipidemic rat heart showed enhanced I/R-induced myocardial injury with high degree of oxidative stress as compared with normal rat heart subjected to I/R. Four episodes of IPC (5 min each) afforded cardioprotection against I/R-induced myocardial injury in normal rat heart as assessed in terms of improvement in coronary flow rate and reduction in myocardial infarct size, LDH, CK-MB and oxidative stress. On the other hand, IPC mediated myocardial protection against I/R-injury was abolished in hyperlipidemic rat heart. However, Treatment with Fenofibrate (100 mg/kg/day, i.p.), Clofibrate (300mg/kg/day, i.p.) as a agonists of PPAR-�± have not affected the cardioprotective effect of IPC in normal rat heart, but its treatment markedly restored the cardioprotective potentials of IPC in hyperlipidemic rat heart. Conclusion: It is noted that the high degree of oxidative stress produced in hyperlipidemic rat heart during reperfusion and consequent down regulation of PPAR-�± may be responsible to abolish the cardioprotective potentials of IPC.
Teaching/Research Experiences: More than 13 Years. I have published more than 53 research/review papers in reputed International & National journals. Moreover I have attended more than 35 International/National conferences as Invited Speaker/LOC Member/Resource Person/Organising Secretary/Presenter etc. Supervised more than 55 PG & UG Research Scholars & going on.
E-mail: dr_sugga@yahoo.co.in